Here are Tuesday's biggest analyst calls of the day: Apple, SpaceX, Nvidia, Palantir, Marvell, Bloom Energy & more

Wall Street analysts issued several upgrades and reiterated buy or outperform ratings, including KeyBanc’s Howmet Aerospace upgrade to overweight with a $237 target and Goldman Sachs’ SiriusXM upgrade to buy with a $37 target. Bank of America downgraded Marvell to neutral and cut its price target to $225 from $400, citing potential overhang from its announced all-stock Lumentum deal and sector multiple contraction. Other calls included positive views on Apple, Palantir, Pony AI, Nano Nuclear Energy, Nvidia, Cloudflare, Bloom Energy, and selected insurance brokers; the roundup reports analyst opinions rather than company-wide results or market reactions.

Analysis

This analyst-call roundup is a weak standalone signal: the more useful read-through is a split between near-term estimates and longer-dated optionality. MRVL has the clearest immediate risk: an all-stock LITE transaction can keep attention on dilution, integration and sector-multiple compression even if estimates are unchanged. That is a company-specific overhang layered on broader semiconductor valuation risk, not evidence that LITE’s operating outlook has worsened.

Over 1–3 months, BE’s deposits and supply commitments are demand indicators, but not proof of profitable growth; working-capital needs and free-cash-flow conversion could disappoint. For HWM, the upgrade rests on 2027+ expectations, so order visibility and execution matter more than the recent relative share move. NET’s pullback may improve entry valuation, but the premium remains high and the call alone does not establish a floor.

The contrarian point: several upgrades lean on distant or hard-to-value optionality—SIRI spectrum/advertising, ECHO assets, NNE’s nuclear opportunity. These may attract flows before cash flows are verifiable. ECHO’s cited value depends on transaction mechanics, asset liabilities and the status and treatment of the referenced SPCX shares; do not treat broker asset estimates as realizable proceeds. Falsifiers include MRVL deal-term changes or revised guidance, BE deposits failing to translate into cash, and HWM order/growth expectations being cut. The aggregate mildly bullish tone is not a broad sector catalyst.

Key Decisions for Investors

• Relative-value watch: underweight MRVL versus a diversified semiconductor exposure rather than shorting the whole AI complex. Reassess when deal terms, expected dilution/integration costs and management guidance are clearer; reduce the bearish stance if the overhang fades without estimate cuts. No price target is supported by the supplied information.
• BE: wait for a quarter showing deposits and commitments converting into revenue and cash flow before adding exposure. A deterioration in free-cash-flow conversion despite rising demand indicators would falsify the bullish operating thesis.
• ECHO/SPCX: keep the asset-value thesis on a watchlist, not as an arbitrage. Verify share rights and closing mechanics, spectrum/DBS liabilities, and the status of the transaction before comparing stated asset values with ECHO’s market value.
• Treat the AAPL, PLTR, NVDA, PONY, NNE, SIRI, AON/MRSH and NET calls as low-incremental-information absent new operating data. For SIRI and NNE in particular, require evidence that optionality can become funded, measurable cash flows before paying for it.